UNSPSC 51273100: Anaesthetic pregnanes

Anaesthetics based on saturated derivatives of the steroid pregnane.

UNSPSC 51273100 Anaesthetic pregnanes is a Class code nominally focused on a narrow pharmaceutical compound class, but recent state and local procurement activity under this code shows minimal relevance to the code's abstract scope. The three recent opportunities posted under this classification—a Seminole County, Florida IFB for naloxone and drug deactivation systems; a Texas Health and Human Services Commission RFI for direct-to-manufacturer prescription programs; and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products—bear no meaningful connection to anaesthetic pregnanes specifically. Instead, they reflect broader state and local pharmaceutical procurement spanning emergency response supplies, pharmacy benefit innovation, and cooperative purchasing arrangements for generic drugs and over-the-counter products. The issuing bodies range from individual county health departments to state agencies and multi-state purchasing cooperatives, indicating that the code as currently tagged captures generalized pharmaceutical sourcing rather than a specialized compound category.

Geographic activity appears concentrated in Florida, Texas, and Minnesota based on recent postings, though the MMCAP opportunity extends to participating states including Oregon. The most concrete opportunity is Seminole County's IFB (IFB60459723LAS), posted June 30, 2026, with a due date of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county's Community Health Building, fixed-fee pricing, and a two-year initial term with a one-year renewal option. The Texas HHS Commission's RFI (HHS0017013), posted April 3, 2026, focuses on exploratory vendor capabilities for direct-to-manufacturer prescription contracting outside traditional pharmacy benefit manager channels—a preliminary information-gathering phase rather than a formal award vehicle. MMCAP's RFP (S1070000015802), posted January 20, 2026, with a March 26, 2026 due date, targets generic pharmaceutical and OTC product supply through three authorized wholesalers, with award effective July 1, 2026, and vendor pricing weighted at 75 percent of evaluation criteria. The code's current tagging suggests a taxonomy misalignment rather than active market demand for anaesthetic pregnanes specifically in state and local procurement.